You are here:  Home
Latest news

EU Commission approves Xadago (safinamide) for mid-late stage Parkinson's disease patients

Zambon S.p.A., an international pharmaceutical company strongly committed to the Central Nervous System (CNS) therapeutic are
27-02-2015
Read more
 

Parkinson's disease patients have reduced visual contrast acuity

Patients with Parkinson's disease (PD) often have difficulties with visual acuity in low-contrast images.
27-02-2015
Read more
 

Researchers develop a molecule that may slow Parkinson's disease

Parkinson's disease arises when misshapen proteins form fibrils that kill brain cells. Now, researchers have made a sticky pe
26-02-2015
Read more
3 reasons to become a member
Free subscription to our journal
Access to hot scientific items
Discounts to our publications
 
 
Twitter
PRDAssociation: Please check out our eCME online courses!!! http://t.co/8p1xJhYDq5http://t.co/Ze2YMPqPDl
1 year, 8 months ago
Members only